NCT05304065

Brief Summary

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,600

participants targeted

Target at P75+ for phase_2

Timeline
5mo left

Started Oct 2022

Typical duration for phase_2

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Oct 2022Dec 2026

First Submitted

Initial submission to the registry

March 11, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

4.2 years

First QC Date

March 11, 2022

Last Update Submit

December 24, 2025

Conditions

Keywords

self-harm

Outcome Measures

Primary Outcomes (2)

  • Suicide Attempts: Primary Clinical Outcome

    suicide attempts fatal, nonfatal, and interrupted

    Through 12 months of follow-up

  • Mental Health Treatment Initiation: Primary Service Use Outcome

    initiation of mental health treatment after discharge from ED/hospital

    Observed through 12 months of follow-up, primary end point 6-month follow-up

Secondary Outcomes (2)

  • Self-Harm: Secondary Clinical Outcome

    Through 12 months of follow-up

  • Treatment engagement: Secondary Service Use Outcome

    Through 12 months of follow-up

Other Outcomes (2)

  • Ordinal suicidality scale: Clinical

    Through 12 months of follow-up

  • Quality of life and functioning: Clinical

    Change from baseline through 12 months of follow-up

Study Arms (2)

SAFETY-Acute within Usual ED Care

ACTIVE COMPARATOR

The SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.

Behavioral: SAFETY-A within usual ED Care

Combined

ACTIVE COMPARATOR

The combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.

Behavioral: Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts

Interventions

SAFETY-A is a single session collaborative, strengths-based, developmentally nuanced, cognitive-behavioral intervention (CBT) to increase safety and mental health treatment initiation. The therapist works with the youth and family (or significant other, SO) separately and together to build hope and reasons for living, develop a personal safety plan, increase protective supports; and increase motivation for and linkage to treatment.

Also known as: Family Intervention for Suicide Prevention (FISP)
SAFETY-Acute within Usual ED Care

COMB, includes SAFETY-A within usual ED care plus CLASP therapeutic and caring follow-up contacts designed to strengthen safety and treatment initiation and engagement. Core functions of CLASP include: building hope/reducing hopelessness; enhancing social/family support; strengthening problem-solving; and increasing treatment initiation and engagement.

Combined

Eligibility Criteria

Age13 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age 13-24;
  • past-week suicidal behavior or ideation with plan or intent

You may not qualify if:

  • symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information);
  • youth not fluent in English
  • parent not fluent in English or Spanish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Ronald Reagan Medical Center

Los Angeles, California, 90095-6968, United States

RECRUITING

Olive View UCLA Education and Research Center

Sylmar, California, 91342, United States

RECRUITING

Duke University

Durham, North Carolina, 27708, United States

RECRUITING

Brown University

Providence, Rhode Island, 02912, United States

RECRUITING

University of Utah

Salt Lake City, Utah, 84112, United States

RECRUITING

Related Links

MeSH Terms

Conditions

SuicideSelf-Injurious Behavior

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Joan R Asarnow, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • David Goldston, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lucas Zullo, PhD

CONTACT

Jocelyn I Meza, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
It is not possible to mask intervention condition from participants. Care providers in the ED will be masked to randomized condition. Outcomes assessors will be masked to randomized condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry & Biboehavioral Sciences

Study Record Dates

First Submitted

March 11, 2022

First Posted

March 31, 2022

Study Start

October 17, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 31, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Decision will be made with PCORI, project investigators, and stakeholders regarding any data sharing. Given relative rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possible of unintended loss of anonymity due to focus on rare outcome.

Shared Documents
STUDY PROTOCOL
Time Frame
A limited data set may be available after all data are complete, analyzed, and published. Time frame and plan will be developed by investigators in collaboration with stakeholders and funding agency (PCORI).
Access Criteria
Decision will be made with PCORI, project investigators, and stakeholders regarding any data access. Given rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possibility of unintended loss of anonymity due to focus on rare outcomes.

Locations